Training scientists to improve immune monitoring in patients
Mentoring Translational Scientists in Clinical Trial Immune Monitoring
This study is all about helping doctors who research autoimmune diseases and cancer treatments learn better ways to find out which patients might need special care or respond well to certain therapies, so they can improve health outcomes for everyone involved.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11123122 on NIH RePORTER |
What this research studies
This research focuses on mentoring physician-scientists to enhance their skills in patient-oriented research, particularly in the areas of autoimmunity and cancer immunotherapy. The project utilizes advanced methodologies to develop diagnostic and predictive classifiers that help identify patients at risk of disease progression or those likely to respond to specific therapies. By creating a detailed map of the human serum glycome, the research aims to discover new biomarkers that can improve patient outcomes. The principal investigator, Dr. Maverakis, is dedicated to training the next generation of clinical investigators through structured mentoring and collaboration.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with autoimmune conditions or cancer who are undergoing immunotherapy.
Not a fit: Patients with non-autoimmune conditions or those not receiving immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment strategies for patients with autoimmune diseases and cancer.
How similar studies have performed: Previous research has shown success in using advanced methodologies for biomarker discovery and patient stratification in similar contexts.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Maverakis, Emanual M. — University of California at Davis
- Study coordinator: Maverakis, Emanual M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.